SCHEMBL96049

SCHEMBL96049

OCCCCOCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
EPHX2 P34913 2/20 0.49
LTA4H P09960 1/20 0.49
GBA1 P04062 2/20 0.48
UGCG Q16739 2/20 0.48
GBA2 Q9HCG7 2/20 0.48
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
HRH4 Q9H3N8 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
NAAA Q02083 2/20 0.43
TEAD3 Q99594 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27600504 0.98 TSHR (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL28955079 0.98 TSHR (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL96809 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL9684333 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL1007794 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL25208054 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL97795 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL8482826 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL814418 0.98 L3MBTL1 (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H
SCHEMBL26189846 0.98 TSHR (0.54) TSHRL3MBTL1TDP1EPHX2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113861066-B Deuterated fluvoxamine maleate and synthesis method thereof 青岛职业技术学院 2023-08-22 CN claimed
CN-113174282-B Preparation method of environment-friendly phosphate flame-retardant hydraulic oil 安徽中天石化股份有限公司 2022-04-12 CN claimed
CN-113861066-A Deuterated maleic acid fluvoxamine and synthesis method thereof 青岛职业技术学院 2021-12-31 CN claimed
CN-113174282-A Preparation method of environment-friendly phosphate flame-retardant hydraulic oil 安徽中天石化股份有限公司 2021-07-27 CN claimed
CN-103755678-B Preparation of cyclicpolybutylece terephthalate dimer 天津阿尔塔科技有限公司 2017-02-15 CN claimed
CN-103755677-B The preparation of ring-type three polybutylene terephthalate (PBT)s 天津阿尔塔科技有限公司 2016-09-28 CN claimed
CN-103146481-B Method for preparing tobacco maillard reaction spice HUABAO FOOD FLAVORS AND FRAGRANCES SHANGHAI CO LTD 2014-05-28 CN claimed
CN-103755677-A Preparation of cyclicpolybutylece terephthalatetrimer ZHANG LEI 2014-04-30 CN claimed
CN-103146481-A Method for preparing tobacco maillard reaction spice HUABAO FOOD FLAVORS AND FRAGRANCES SHANGHAI CO LTD 2013-06-12 CN claimed
CN-100352913-C Wall breaking method of microalgae cell INST OF OEANOLGRAPHY CAS (CN) 2007-12-05 CN claimed
CN-1786148-A Wall breaking method of microalgae cell INST OF OEANOLGRAPHY CAS (CN) 2006-06-14 CN claimed
WO-2003048080-A1 METHODS FOR THE SEPARATION OF ISOMERS GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (NZ) 2003-06-12 WO claimed
JP-8225732-A None JP disclosed
EP-4142732-B1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2026-04-22 EP disclosed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 US disclosed
EP-4720058-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF Casma Therapeutics, Inc. (US) 2026-04-08 EP disclosed
EP-0046710-A1 Preparation of aminoacetonitrile derivatives MERRELL TORAUDE ET COMPAGNIE (FR) 1982-03-03 EP disclosed
US-4174458-A Novel analogues of prostanoic acids not occurring in nature HOECHST AKTIENGESELLSCHAFT (DE) 1979-11-13 US disclosed
US-4098815-A BRONCHODILATOR AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1978-07-04 US disclosed
US-4017524-A PRINTING AND DYEING OF SYNTHETIC FIBERS BAYER AKTIENGESELLSCHAFT (DT) 1977-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600699-B2 Thiosemicarbazates and uses thereof MET, THRB, ABAT TSHR 17/4885L3MBTL1 184/4885TDP1 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.